Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Dishman Pharmaceuticals and Chemicals

Latest From Dishman Pharmaceuticals and Chemicals

India’s Contract Manufacturing: Prospects And Pains

Is the general uptrend in India's contract manufacturing segment sustainable, despite some sentiment-dampening run-ins with regulators over compliance concerns?

BioPharmaceutical India

Dishman Pharma To Sell India Facility Land to Nirma To Help Defray Debt

India's Dishman Pharmaceuticals and Chemicals is reported in discussion with possible buyers for the 432 acres of land its Gujarat facilities occupy, along with selling is Shanghai facility, according to sources.

BioPharmaceutical India

Dishman Seeks $25 Million For Newly Open China Production Facility

Dishman Pharmaceuticals and Chemicals is offering its plant in China for sale even as it begins production of intermediates after years of regulatory delays.

BioPharmaceutical India

India's Generic API Makers Look To Japan As Next Big Growth Market

Dishman Pharmaceuticals and Chemicals, Suvan Lifesciences, Ind-Swift Labs and other India makers of generic bulk drugs are looking to Japan as their next big market.

BioPharmaceutical India
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Carbogen Amcis
    • Dishman Biotech